Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease

British Journal of Surgery

Volumn 91, Issue 1, 2004, Pages 72-77

  Beddy, D ^a   Watson, R W G ^a   Fitzpatrick, J M ^a   O'Connell, P R ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ADULT; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; COLON STENOSIS; CONFERENCE PAPER; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROSA; SUPERNATANT;

ADULT; ANALYSIS OF VARIANCE; CROHN DISEASE; FIBROBLASTS; HUMANS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1642540081     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4453     Document Type: Conference Paper

References (30)

1. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease: relationship between clinical patterns and prognosis. Gastroenterology 1985; 88: 1818-1825.
2. Graham MF, Diegelmann R, Elson CO, Lindblad WJ, Gotschalk N, Gay S et al. Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology 1988; 94: 257-265.
3. Stallmach A, Schuppan D, Riese HH, Matthes H, Riecken EO. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease. Gastroenterology 1992; 102: 1920-1929.
4. Brannigan AE, Watson RW, Beddy D, Hurley H, Fitzpatrick JM, O'Connell PR. Increased adhesion molecule expression in serosal fibroblasts isolated from patients with inflammatory bowel disease is secondary to inflammation. Ann Surg 2002; 235: 507-511.
5. Regan MC, Flavin BM, Fitzpatrick JM, O'Connell PR. Stricture formation in Crohn's disease: the role of intestinal fibroblasts. Ann Surg 2000; 231: 46-50.
6. Wakefield AJ, Sawyer AM, Dhillon A, Pittilo RM, Rowles PM, Lewis AA et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989; ii: 1057-1062.
7. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted mitogen. Science 1989; 246: 1306-1309.
8. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 1994; 269: 6271-6274.
9. Berse B, Hunt JA, Diegel RJ, Morganelli P, Yeo K, Brown F et al. Hypoxia augments cytokine (TGF-β and IL-1) induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 1999; 115: 176-182.
10. Chua C, Hamdy R, Chua B. Mechanism of transforming growth factor beta-1 induced expression of vascular endothelial growth factor expression in murine osteoblastic MC3T3-E1 cells. Biochim Biophys Acta 2000; 1497: 69-76.
11. Donovan D, Harmey JH, Toomey D, Osborne DH, Redmond HP, Bouchier-Hayes DJ. TGF beta-1 regulation of VEGF production by breast cancer cells. Ann Surg Oncol 1997; 4: 621-627.
12. Griga T, Werner S, Koller M, Tromm A, May B. Vascular endothelial growth factor (VEGF) in Crohn's disease: increased production by peripheral blood mononuclear cells and decreased VEGF165 labeling of peripheral CD14+ monocytes. Dig Dis Sci 1999; 44: 1196-1201.
13. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Biol 1995; 11: 73-91.
14. Ferrara N. Vascular endothelial growth factor. Eur J Cancer 1996; 32A: 2413-2422.
15. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti P et al. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocytes procoagulant activity, and promotes monocytes migration. J Exp Med 1990; 172: 1535-1545.
16. Suzuma K, Naruse K, Suzuma I, Takahara N, Ueki K, Aiello L et al. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Fltl and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem 2000; 275: 40725-40731.
17. Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B et al. Vascular permeability factor/vascular endothelial growth factor (VPF: VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994; 180: 341-346.
18. Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti M, Guiducci S et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 2002; 4: R11.
19. Bousavaros A, Leichtner A, Zurakowski D, Kwon J, Law T, Keough K et al. Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease. Dig Dis Sci 1999; 44: 424-430.
20. Griga T, Tromm A, Spranger J, May B. Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand J Gastroenterol 1998; 33: 504-508.
21. Griga T, Gutzeit A, Sommerkamp C, May B. Increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999; 11: 175-179.
22. Griga T, Hebler U, Voight E, Tromm A, May B. Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease. Hepatogastroenterology 2000; 47: 1604-1607.
23. Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K. VEGF, basic-FGF, and TGF-β in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 2001; 96: 822-828.
24. Griga T, Voight E, Gretzer B, Brasch F, May B. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Hepatogastroenterology 1999; 46: 920-923.
25. Fehrenbach H, Haase M, Kasper M, Koslowski R, Schuh D, Muller M. Alterations in the immunohistochemical distribution patterns of vascular endothelial growth factor receptors Flk1 and Flt1 in bleomycin-induced rat lung fibrosis. Virchows Arch 1999; 435: 20-31.
26. Fehrenbach H, Kasper M, Haase M, Schuh D, Muller M. Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: Light, fluorescence, and electron microscopy. Anat Rec 1999; 254: 61-73.
27. Beddy D, Watson RWG, Fitzpatrick JM, O'Connell PR. TNF-α and IL-1β regulate fibroblast ICAM-1 expression in Crohn's disease through a jun kinase pathway. J Am Coll Surg 2002; 19S(Suppl): S12 (Abstract).
28. Pucilowska JB, McNaughton KK, Mohapatra NK, Hoyt EC, Zimmermann EM, Sartor RB et al. IGF-1 and procollagen α1(I) are coexpressed in a subset of mesenchymal cells in active Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2000; 279: 1307-1322.
29. di Mola FF, Friess H, Scheuren A, Di Sebastiano P, Graber H, Egger B et al. Transforming growth factor-β and their signalling receptors are coexpressed in Crohn's disease. Ann Surg 1999; 229: 67-75.
30. Nagashima M, Wauke K, Hirano D, Ishigami S, Aono H, Takai M et al. Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis. Rheumatology 2000; 39: 1255-1262.